Shopping Cart 0
Cart Subtotal
AED 0

Global Genome Editing Market Forecast to 2025

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 10093

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 12845

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 16515
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Global Genome Editing Market-Drivers, Restraints, Opportunities, Trends, and Forecast, 2019-2025

[98 pages report] This market research report includes a detailed segmentation of the global genome editing market-by technology (CRISPR, TALEN, ZFN, and Others), by application (Cell Line Engineering, Genetic Engineering, and Others), By end-user (Research Institutes, Biotechnology and Pharmaceutical Companies, and Contract Research Organizations), by regions (North America, Europe, Asia Pacific, and Rest of the World).

Overview of the Global Genome Editing Market

Infoholic's market research report predicts that the Global Genome Editing Market will grow at a CAGR of 14.4% during the forecast period. The market has witnessed steady growth in the past few years with the development in technology and the introduction of highly sensitive, robust, and reliable systems in the market. The market is fueled due to increase in genetic disorders, increasing investment and funds, and technological advancements in genome editing.

 

 

The market continues to grow and is one of the increasingly accepted market in many countries worldwide. Vendors are focusing towards obtaining funds and collaborating with universities to enlarge their research and development capabilities. The majority of the revenue is generated from the leading players in the market with dominating sales of ThermoFisher Scientific, GenScript Corp., Sangamo Therapeutics, Lonza Group, and Horizon Discovery Group plc.

According to Infoholic Research analysis, North America accounted for the largest share of the global genome editing market in 2018. US dominates the market with majority of genome editing companies being located in this region. However, China has not been too far behind and has great government support for the research in genome editing field.

By Technology:

CRISPR

TALEN

ZFN

Others

In 2018, the CRISPR segment occupied the largest share due to specific, effective, and cost-effective nature of the technology. Many companies are focusing on providing genome editing services. For instance, in January 2019, Horizon Discovery extended CRISPR screening service to primary human T cells.

By Applications:

Cell Line Engineering

Genetic Engineering

Others

In 2018, the cell line engineering accounted the maximum share followed by genetic engineering. Increase in the number of people suffering with genetic disorders has driven the growth of the genome editing market.

By End Users:

Research Institutes

Biotechnology and Pharmaceutical Companies

Contract Research Organizations

In 2018, the biotechnology and pharmaceutical companies gained the highest market share for genome editing market due to increased pervasiveness of cancer and infectious diseases are driving research goings-on in biotechnology & pharmaceutical companies segment.

By Regions:

North America

Europe

APAC

ROW

The market is dominated by North America, followed by Asia Pacific and Europe. The major share of the North America market is from the US due to quick adoption of new and advanced technologies.

Genome Editing Market Research Competitive Analysis-The market is extremely fragmented with several smaller companies struggling for market share. Big pharmaceutical establishments have also united with venture capitalists to provide funding to the start-ups. In 2015, Bayer financed USD 335 million and in the very same year, Celgene combined with Abingworth invested USD 64 million in CRISPR Therapeutics. The NIH recently granted 21 somatic cell genome editing grants of almost USD 86 million over the next half a decade. These endowments are the foremost to be granted through the Somatic Cell Genome Editing (SCGE) program that was initiated in January 2018 with NIH Common Fund.

The companies are collaborating and licensing to increase their capabilities in the market. CRISPR, TALEN, ZFN, Meganuclease, ARCUS, and RTDS are some of the key technology areas concentrated by key players in the market. Since 2015, the deals on the CRISPR technology has drastically increased.

Key vendors:

ThermoFisher Scientific

GenScript Corp.

Sangamo Therapeutics

Lonza Group

Horizon Discovery Group plc

Merck KGaA

Transposagen Biopharmaceutical

CRISPR Therapeutics

Editas Medicine

Integrated DNA Technologies

New England Biolabs

Origene Technologies, Inc.

Key competitive facts -

Genetic editing technologies are intensely evolving from previous two decades and has facilitated in the variation of genome further rapidly and in a less expensive technique.

The US is the leader in the CRISPR technology, while the market for TALEN genome editing technology is dominated by China.

Benefits-The report provides complete details about the usage and adoption rate of genome editing market. Thus, the key stakeholders can know about the major trends, drivers, investments, vertical player's initiatives, and government initiatives towards the healthcare segment in the upcoming years along with details of the pureplay companies entering the market. Moreover, the report provides details about the major challenges that are going to impact the market growth. Additionally, the report gives complete details about the key business opportunities to key stakeholders in order to expand their business and capture the revenue in specific verticals, and to analyze before investing or expanding the business in this market.

Key Takeaways:

Understanding the potential market opportunity with precise market size and forecast data

Detailed market analysis focusing on the growth of genome editing industry

Factors influencing the growth of genome editing market

In-depth competitive analysis of dominant and pureplay vendors

Prediction analysis of genome editing market in both developed and developing regions

Key insights related to major segments of the genome editing market

Latest market trend analysis impacting the buying behavior of the consumers

 

Key Stakeholders -

 

 

 

 

READ MORE

Table Of Content

Scope

Table of Contents

1 Industry Outlook 9

1.1 Industry Overview 9

1.2 Total Addressable Market 9

1.2.1 Industry Trends 10

2 Report Outline 11

2.1 Report Scope 11

2.2 Report Summary 11

2.3 Research Methodology 13

2.4 Report Assumptions 13

3 Market Snapshot 14

3.1 Market Definition-Infoholic Research 14

3.2 Segmented Addressable Market (SAM) 14

3.3 Industry Trends 15

3.4 Related Markets 16

3.4.1 Genetic Testing 16

3.4.1.1 Trends of the genetic testing market 16

3.4.2 Liquid Biopsy Market 16

3.4.2.1 Trends of Liquid biopsy market 17

3.4.3 Next-generation sequencing 18

3.4.3.1 Trends in the Next-generation sequencing market 18

4 Market Outlook 19

4.1 Funding Scenario 19

4.2 International Patent Classification (IPC) Codes and for the Technology Areas 20

4.2.1 Life Science Research 20

4.2.2 General Research 21

4.3 Deals 21

4.4 Porter 5 (Five) Forces 26

5 Market Characteristics 28

5.1 Evolution 28

5.2 Market Segmentation 29

5.3 Market Dynamics 30

5.3.1 Drivers 30

5.3.1.1 Increase in Genetic Disorders 30

5.3.1.2 Increasing Investment and Funds 31

5.3.1.3 Technological Advancements in Genome Editing 31

5.3.2 Restraints 31

5.3.2.1 Ethical Concerns Associated to Genetic Editing 31

5.3.2.2 High Cost of Genome Engineering Technologies 32

5.3.3 Opportunities 32

5.3.3.1 Market Expansion Opportunities in Emerging Nations 32

5.3.3.2 Growing Collaboration for Genome Engineering Technologies 32

5.3.4 DRO-Impact Analysis 33

5.4 Key Stakeholders 34

6 Technology Types: Market Size and Analysis 35

6.1 Overview 35

6.2 CRISPR/Clustered Regularly Interspaced Short Palindromic Repeats 36

6.3 TALEN/Transcription Activator-Like Effector Nuclease 39

6.4 ZFN/Zinc-Finger Nucleases 40

6.5 Others 41

7 Application Types: Market Size and Analysis 43

7.1 Overview 43

7.2 Cell Line Engineering 44

7.3 Genetic Engineering 45

7.4 Others 48

8 End Users: Market Size and Analysis 50

8.1 Overview 50

8.2 Research Institutes 50

8.3 Biotechnology and Pharmaceutical Companies 51

8.4 Contract Research Organizations 52

9 Regions: Market Size and Analysis 53

9.1 Overview 53

9.2 North America 54

9.2.1 Overview 54

9.3 Europe 55

9.3.1 Overview 55

9.4 Asia Pacific 56

9.4.1 Overview 56

9.5 Rest of the World 57

9.5.1 Overview 57

10 Competitive Landscape 59

11 Vendors Profile 64

11.1 ThermoFisher Scientific, Inc. 64

11.1.1 Overview 64

11.1.2 Business Units 66

11.1.3 Geographic Presence 67

11.1.4 Business Focus 68

11.1.5 SWOT Analysis 68

11.1.6 Business Strategy 69

11.2 GenScript Corp. 70

11.2.1 Overview 70

11.2.2 Business Units 71

11.2.3 Geographic Presence 72

11.2.4 Business Focus 73

11.2.5 SWOT Analysis 73

11.2.6 Business Strategies 74

11.3 SANGAMO THERAPEUTICS, INC. 74

11.3.1 Overview 74

11.3.2 Business Focus 76

11.3.3 SWOT Analysis 77

11.3.4 Business Strategies 77

11.4 Lonza Group 78

11.4.1 Overview 78

11.4.2 Business Units 79

11.4.3 Geographic Presence 80

11.4.4 Business Focus 81

11.4.5 SWOT Analysis 81

11.4.6 Business Strategies 82

11.5 Horizon Discovery Group plc 82

11.5.1 Overview 82

11.5.2 Business Units 85

11.5.3 Geographic Presence 86

11.5.4 Business Focus 87

11.5.5 SWOT Analysis 87

11.5.6 Business Strategies 88

12 Companies to Watch for 89

12.1 Merck KGaA 89

12.1.1 Overview 89

12.2 Transposagen Biopharmaceuticals 90

12.2.1 Overview 90

12.3 CRISPR Therapeutics 91

12.3.1 Overview 91

12.4 Editas Medicine 92

12.4.1 Overview 92

12.5 Integrated DNA Technologies 93

12.5.1 Overview 93

12.6 New England Biolabs 94

12.6.1 Overview 94

12.7 Origene Technologies, Inc. 95

12.7.1 Overview 95

Annexure 97

? Acronyms 97

 

 


List Of Figure

Charts

 

CHART 1 RESEARCH METHODOLOGY OF GLOBAL GENOME EDITING MARKET 13

CHART 2 GLOBAL GENOME EDITING MARKET REVENUE, 2018-2025 (USD MILLION) 16

CHART 3 PORTERS 5 FORCES ON GLOBAL GENOME EDITING MARKET 27

CHART 5 GLOBAL GENOME EDITING MARKET SEGMENTATION 30

CHART 6 MARKET DYNAMICS-DRIVERS, RESTRAINTS & OPPORTUNITIES 31

CHART 7 DRO-IMPACT ANALYSIS OF GLOBAL GENOME EDITING MARKET 34

CHART 8 KEY STAKEHOLDERS OF GENOME EDITING MARKET 35

CHART 9 GENOME EDITING MARKET SEGMENT REVENUE BY TECHNOLOGY TYPE, 2018 VS 2025 (USD MILLION) 37

CHART 10 CRISPR GENOME EDITING MARKET REVENUE 2018-2025 (USD MILLION) 39

CHART 11 CRISPR GENOME EDITING MARKET REVENUE, BY REGION 2018 (%SHARE) 39

CHART 12 TALEN GENOME EDITING MARKET REVENUE 2018-2025 (USD MILLION) 40

CHART 13 ZFN GENOME EDITING MARKET REVENUE 2018-2025 (USD MILLION) 42

CHART 14 OTHER GENOME EDITING MARKET REVENUE 2018-2025 (USD MILLION) 43

CHART 15 GENOME EDITING MARKET SEGMENT REVENUE. BY APPLICATION TYPE, 2018 VS 2025 (USD MILLION) 44

CHART 16 CELL LINE ENGINEERING MARKET REVENUE 2018-2025 (USD MILLION) 46

CHART 17 GENETIC ENGINEERING MARKET REVENUE 2018-2025 (USD MILLION) 48

CHART 18 GENETIC ENGINEERING MARKET REVENUE, BY APPLICATION TYPES, 2018-2025 (USD MILLION) 48

CHART 19 OTHER GENOME EDITING MARKET REVENUE 2018-2025 (USD MILLION) 50

CHART 20 GENOME EDITING MARKET SEGMENT REVENUE BY END USERS, 2018 (%) 51

CHART 21 TOP PUBLISHING ORGANIZATIONS FOR RESEARCH IN LIFE SCIENCE GENOME EDITING 52

CHART 22 GENOME EDITING MARKET BY REGIONAL SEGMENTATION, 2018 VS 2025 (USD MILLION) 54

CHART 23 GENOME EDITING MARKET REVENUE IN NORTH AMERICA, 2018-2025 (USD MILLION) 56

CHART 24 GENOME EDITING MARKET REVENUE IN EUROPE 2018-2025 (USD MILLION) 57

CHART 25 GENOME EDITING MARKET REVENUE IN ASIA PACIFIC, 2018-2025 (USD MILLION) 58

CHART 26 GENOME EDITING REVENUE IN REST OF THE WORLD, 2018-2025 (USD MILLION) 59

CHART 27 THERMO FISHER SCIENTIFIC: OVERVIEW SNAPSHOT 66

CHART 28 THERMO FISHER SCIENTIFIC: BUSINESS UNITS 67

CHART 29 THERMO FISHER SCIENTIFIC: GEOGRAPHIC PRESENCE 68

CHART 30 THERMO FISHER SCIENTIFIC: SWOT ANALYSIS 69

CHART 31 GENSCRIPT CORPORATION: OVERVIEW SNAPSHOT 71

CHART 32 GENSCRIPT CORPORATION: BUSINESS UNITS 72

CHART 33 GENSCRIPT CORP.: GEOGRAPHIC PRESENCE 73

CHART 34 GENSCRIPT CORPORATION: SWOT ANALYSIS 74

CHART 35 SANGAMO THERAPEUTICS, INC.: OVERVIEW SNAPSHOT 76

CHART 36 SANGAMO THERAPEUTICS, INC.: SWOT ANALYSIS 78

CHART 37 LONZA GROUP: OVERVIEW SNAPSHOT 79

CHART 38 LONZA GROUP: BUSINESS UNITS 80

CHART 39 LONZA GROUP: GEOGRAPHIC PRESENCE 81

CHART 40 LONZA GROUP: SWOT ANALYSIS 82

CHART 41 HORIZON DISCOVERY GROUP PLC: OVERVIEW SNAPSHOT 85

CHART 42 HORIZON DISCOVERY GROUP PLC: BUSINESS UNITS 86

CHART 43 HORIZON DISCOVERY GROUP PLC: GEOGRAPHIC PRESENCE 87

CHART 44 HORIZON DISCOVERY GROUP PLC: SWOT ANALYSIS 88

 


List Of Table

Tables

 

TABLE 1 DEALS BETWEEN 2011-2016 23

TABLE 2 GENOME EDITING MARKET REVENUE, BY TECHNOLOGY TYPE, 2018-2025 (USD MILLION) 37

TABLE 3 GENOME EDITING MARKET REVENUE, BY APPLICATION TYPE, 2018-2025 (USD MILLION) 44

TABLE 4 GENOME EDITING MARKET REVENUE, BY PRODUCT TYPE, 2018-2025 (USD MILLION) 55

TABLE 5 COST COMPARISION OF GENOME EDITING TECHNOLOGY 60

TABLE 6 KEY DEVELOPMENTS IN THE MARKET 61

TABLE 7 THERMO FISHER SCIENTIFIC: PRODUCT OFFERINGS 65

TABLE 8 THERMO FISHER SCIENTIFIC: RECENT DEVELOPMENTS 66

TABLE 9 GENSCRIPT CORPORATION: PRODUCT OFFERINGS 71

TABLE 10 GENSCRIPT CORPORATION: RECENT DEVELOPMENTS 71

TABLE 11 SANGAMO THERAPEUTICS, INC.: PRODUCT OFFERINGS 76

TABLE 12 SANGAMO THERAPEUTICS, INC.: RECENT DEVELOPMENTS 76

TABLE 13 LONZA GROUP: OFFERINGS 79

TABLE 14 LONZA GROUP: RECENT DEVELOPMENTS 79

TABLE 15 HORIZON DISCOVERY GROUP PLC: OFFERINGS 84

TABLE 16 HORIZON DISCOVERY GROUP PLC: RECENT DEVELOPMENTS 84

TABLE 17 MERCK KGAA: SNAPSHOT 90

TABLE 18 MERCK KGAA: RECENT DEVELOPMENTS 90

TABLE 19 TRANSPOSAGEN BIOPHARMACEUTICALS: SNAPSHOT 91

TABLE 20 TRANSPOSAGEN BIOPHARMACEUTICALS: RECENT DEVELOPMENTS 91

TABLE 21 CRISPR THERAPEUTICS: OVERVIEW 92

TABLE 22 CRISPR THERAPEUTICS: RECENT DEVELOPMENTS 92

TABLE 23 EDITAS MEDICINE: OVERVIEW 93

TABLE 24 EDITAS MEDICINE: RECENT DEVELOPMENTS 93

TABLE 25 INTEGRATED DNA TECHNOLOGIES: SNAPSHOT 94

TABLE 26 INTEGRATED DNA TECHNOLOGIES: RECENT DEVELOPMENTS 94

TABLE 27 NEW ENGLAND BIOLABS: OVERVIEW 95

TABLE 28 NEW ENGLAND BIOLABS: RECENT DEVELOPMENTS 95

TABLE 29 ORIGENE TECHNOLOGIES, INC.: OVERVIEW 96

TABLE 30 ORIGENE TECHNOLOGIES, INC.: RECENT DEVELOPMENTS 96

 

?

Licence Rights

"Single User $3,500- PDF via email with only 1 user license terms or online access with login details to customer
- Multi Users $4,000- PDF via email with up to 10 user license terms
- Enterprise License $5,000- PDF via email, can be utilized across the organization and can upload in their intranet.
We do have the online access for our reports where client can utilize our knowledge store and they will have their login details to access the report online instead of PDF file."

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies


Companies

ThermoFisher Scientific

GenScript Corp.

Sangamo Therapeutics

Lonza Group

Horizon Discovery Group plc

Merck KGaA

Transposagen Biopharmaceutical

CRISPR Therapeutics

Editas Medicine

Integrated DNA Technologies

New England Biolabs

Origene Technologies, Inc.

Global Genome Editing Market-Drivers, Restraints, Opportunities, Trends, and Forecast, 2019-2025

[98 pages report] This market research report includes a detailed segmentation of the global genome editing market-by technology (CRISPR, TALEN, ZFN, and Others), by application (Cell Line Engineering, Genetic Engineering, and Others), By end-user (Research Institutes, Biotechnology and Pharmaceutical Companies, and Contract Research Organizations), by regions (North America, Europe, Asia Pacific, and Rest of the World).

Overview of the Global Genome Editing Market

Infoholic's market research report predicts that the Global Genome Editing Market will grow at a CAGR of 14.4% during the forecast period. The market has witnessed steady growth in the past few years with the development in technology and the introduction of highly sensitive, robust, and reliable systems in the market. The market is fueled due to increase in genetic disorders, increasing investment and funds, and technological advancements in genome editing.

 

 

The market continues to grow and is one of the increasingly accepted market in many countries worldwide. Vendors are focusing towards obtaining funds and collaborating with universities to enlarge their research and development capabilities. The majority of the revenue is generated from the leading players in the market with dominating sales of ThermoFisher Scientific, GenScript Corp., Sangamo Therapeutics, Lonza Group, and Horizon Discovery Group plc.

According to Infoholic Research analysis, North America accounted for the largest share of the global genome editing market in 2018. US dominates the market with majority of genome editing companies being located in this region. However, China has not been too far behind and has great government support for the research in genome editing field.

By Technology:

CRISPR

TALEN

ZFN

Others

In 2018, the CRISPR segment occupied the largest share due to specific, effective, and cost-effective nature of the technology. Many companies are focusing on providing genome editing services. For instance, in January 2019, Horizon Discovery extended CRISPR screening service to primary human T cells.

By Applications:

Cell Line Engineering

Genetic Engineering

Others

In 2018, the cell line engineering accounted the maximum share followed by genetic engineering. Increase in the number of people suffering with genetic disorders has driven the growth of the genome editing market.

By End Users:

Research Institutes

Biotechnology and Pharmaceutical Companies

Contract Research Organizations

In 2018, the biotechnology and pharmaceutical companies gained the highest market share for genome editing market due to increased pervasiveness of cancer and infectious diseases are driving research goings-on in biotechnology & pharmaceutical companies segment.

By Regions:

North America

Europe

APAC

ROW

The market is dominated by North America, followed by Asia Pacific and Europe. The major share of the North America market is from the US due to quick adoption of new and advanced technologies.

Genome Editing Market Research Competitive Analysis-The market is extremely fragmented with several smaller companies struggling for market share. Big pharmaceutical establishments have also united with venture capitalists to provide funding to the start-ups. In 2015, Bayer financed USD 335 million and in the very same year, Celgene combined with Abingworth invested USD 64 million in CRISPR Therapeutics. The NIH recently granted 21 somatic cell genome editing grants of almost USD 86 million over the next half a decade. These endowments are the foremost to be granted through the Somatic Cell Genome Editing (SCGE) program that was initiated in January 2018 with NIH Common Fund.

The companies are collaborating and licensing to increase their capabilities in the market. CRISPR, TALEN, ZFN, Meganuclease, ARCUS, and RTDS are some of the key technology areas concentrated by key players in the market. Since 2015, the deals on the CRISPR technology has drastically increased.

Key vendors:

ThermoFisher Scientific

GenScript Corp.

Sangamo Therapeutics

Lonza Group

Horizon Discovery Group plc

Merck KGaA

Transposagen Biopharmaceutical

CRISPR Therapeutics

Editas Medicine

Integrated DNA Technologies

New England Biolabs

Origene Technologies, Inc.

Key competitive facts -

Genetic editing technologies are intensely evolving from previous two decades and has facilitated in the variation of genome further rapidly and in a less expensive technique.

The US is the leader in the CRISPR technology, while the market for TALEN genome editing technology is dominated by China.

Benefits-The report provides complete details about the usage and adoption rate of genome editing market. Thus, the key stakeholders can know about the major trends, drivers, investments, vertical player's initiatives, and government initiatives towards the healthcare segment in the upcoming years along with details of the pureplay companies entering the market. Moreover, the report provides details about the major challenges that are going to impact the market growth. Additionally, the report gives complete details about the key business opportunities to key stakeholders in order to expand their business and capture the revenue in specific verticals, and to analyze before investing or expanding the business in this market.

Key Takeaways:

Understanding the potential market opportunity with precise market size and forecast data

Detailed market analysis focusing on the growth of genome editing industry

Factors influencing the growth of genome editing market

In-depth competitive analysis of dominant and pureplay vendors

Prediction analysis of genome editing market in both developed and developing regions

Key insights related to major segments of the genome editing market

Latest market trend analysis impacting the buying behavior of the consumers

 

Key Stakeholders -

 

 

 

 

READ MORE

Scope

Table of Contents

1 Industry Outlook 9

1.1 Industry Overview 9

1.2 Total Addressable Market 9

1.2.1 Industry Trends 10

2 Report Outline 11

2.1 Report Scope 11

2.2 Report Summary 11

2.3 Research Methodology 13

2.4 Report Assumptions 13

3 Market Snapshot 14

3.1 Market Definition-Infoholic Research 14

3.2 Segmented Addressable Market (SAM) 14

3.3 Industry Trends 15

3.4 Related Markets 16

3.4.1 Genetic Testing 16

3.4.1.1 Trends of the genetic testing market 16

3.4.2 Liquid Biopsy Market 16

3.4.2.1 Trends of Liquid biopsy market 17

3.4.3 Next-generation sequencing 18

3.4.3.1 Trends in the Next-generation sequencing market 18

4 Market Outlook 19

4.1 Funding Scenario 19

4.2 International Patent Classification (IPC) Codes and for the Technology Areas 20

4.2.1 Life Science Research 20

4.2.2 General Research 21

4.3 Deals 21

4.4 Porter 5 (Five) Forces 26

5 Market Characteristics 28

5.1 Evolution 28

5.2 Market Segmentation 29

5.3 Market Dynamics 30

5.3.1 Drivers 30

5.3.1.1 Increase in Genetic Disorders 30

5.3.1.2 Increasing Investment and Funds 31

5.3.1.3 Technological Advancements in Genome Editing 31

5.3.2 Restraints 31

5.3.2.1 Ethical Concerns Associated to Genetic Editing 31

5.3.2.2 High Cost of Genome Engineering Technologies 32

5.3.3 Opportunities 32

5.3.3.1 Market Expansion Opportunities in Emerging Nations 32

5.3.3.2 Growing Collaboration for Genome Engineering Technologies 32

5.3.4 DRO-Impact Analysis 33

5.4 Key Stakeholders 34

6 Technology Types: Market Size and Analysis 35

6.1 Overview 35

6.2 CRISPR/Clustered Regularly Interspaced Short Palindromic Repeats 36

6.3 TALEN/Transcription Activator-Like Effector Nuclease 39

6.4 ZFN/Zinc-Finger Nucleases 40

6.5 Others 41

7 Application Types: Market Size and Analysis 43

7.1 Overview 43

7.2 Cell Line Engineering 44

7.3 Genetic Engineering 45

7.4 Others 48

8 End Users: Market Size and Analysis 50

8.1 Overview 50

8.2 Research Institutes 50

8.3 Biotechnology and Pharmaceutical Companies 51

8.4 Contract Research Organizations 52

9 Regions: Market Size and Analysis 53

9.1 Overview 53

9.2 North America 54

9.2.1 Overview 54

9.3 Europe 55

9.3.1 Overview 55

9.4 Asia Pacific 56

9.4.1 Overview 56

9.5 Rest of the World 57

9.5.1 Overview 57

10 Competitive Landscape 59

11 Vendors Profile 64

11.1 ThermoFisher Scientific, Inc. 64

11.1.1 Overview 64

11.1.2 Business Units 66

11.1.3 Geographic Presence 67

11.1.4 Business Focus 68

11.1.5 SWOT Analysis 68

11.1.6 Business Strategy 69

11.2 GenScript Corp. 70

11.2.1 Overview 70

11.2.2 Business Units 71

11.2.3 Geographic Presence 72

11.2.4 Business Focus 73

11.2.5 SWOT Analysis 73

11.2.6 Business Strategies 74

11.3 SANGAMO THERAPEUTICS, INC. 74

11.3.1 Overview 74

11.3.2 Business Focus 76

11.3.3 SWOT Analysis 77

11.3.4 Business Strategies 77

11.4 Lonza Group 78

11.4.1 Overview 78

11.4.2 Business Units 79

11.4.3 Geographic Presence 80

11.4.4 Business Focus 81

11.4.5 SWOT Analysis 81

11.4.6 Business Strategies 82

11.5 Horizon Discovery Group plc 82

11.5.1 Overview 82

11.5.2 Business Units 85

11.5.3 Geographic Presence 86

11.5.4 Business Focus 87

11.5.5 SWOT Analysis 87

11.5.6 Business Strategies 88

12 Companies to Watch for 89

12.1 Merck KGaA 89

12.1.1 Overview 89

12.2 Transposagen Biopharmaceuticals 90

12.2.1 Overview 90

12.3 CRISPR Therapeutics 91

12.3.1 Overview 91

12.4 Editas Medicine 92

12.4.1 Overview 92

12.5 Integrated DNA Technologies 93

12.5.1 Overview 93

12.6 New England Biolabs 94

12.6.1 Overview 94

12.7 Origene Technologies, Inc. 95

12.7.1 Overview 95

Annexure 97

? Acronyms 97

 

 


List Of Figure

Charts

 

CHART 1 RESEARCH METHODOLOGY OF GLOBAL GENOME EDITING MARKET 13

CHART 2 GLOBAL GENOME EDITING MARKET REVENUE, 2018-2025 (USD MILLION) 16

CHART 3 PORTERS 5 FORCES ON GLOBAL GENOME EDITING MARKET 27

CHART 5 GLOBAL GENOME EDITING MARKET SEGMENTATION 30

CHART 6 MARKET DYNAMICS-DRIVERS, RESTRAINTS & OPPORTUNITIES 31

CHART 7 DRO-IMPACT ANALYSIS OF GLOBAL GENOME EDITING MARKET 34

CHART 8 KEY STAKEHOLDERS OF GENOME EDITING MARKET 35

CHART 9 GENOME EDITING MARKET SEGMENT REVENUE BY TECHNOLOGY TYPE, 2018 VS 2025 (USD MILLION) 37

CHART 10 CRISPR GENOME EDITING MARKET REVENUE 2018-2025 (USD MILLION) 39

CHART 11 CRISPR GENOME EDITING MARKET REVENUE, BY REGION 2018 (%SHARE) 39

CHART 12 TALEN GENOME EDITING MARKET REVENUE 2018-2025 (USD MILLION) 40

CHART 13 ZFN GENOME EDITING MARKET REVENUE 2018-2025 (USD MILLION) 42

CHART 14 OTHER GENOME EDITING MARKET REVENUE 2018-2025 (USD MILLION) 43

CHART 15 GENOME EDITING MARKET SEGMENT REVENUE. BY APPLICATION TYPE, 2018 VS 2025 (USD MILLION) 44

CHART 16 CELL LINE ENGINEERING MARKET REVENUE 2018-2025 (USD MILLION) 46

CHART 17 GENETIC ENGINEERING MARKET REVENUE 2018-2025 (USD MILLION) 48

CHART 18 GENETIC ENGINEERING MARKET REVENUE, BY APPLICATION TYPES, 2018-2025 (USD MILLION) 48

CHART 19 OTHER GENOME EDITING MARKET REVENUE 2018-2025 (USD MILLION) 50

CHART 20 GENOME EDITING MARKET SEGMENT REVENUE BY END USERS, 2018 (%) 51

CHART 21 TOP PUBLISHING ORGANIZATIONS FOR RESEARCH IN LIFE SCIENCE GENOME EDITING 52

CHART 22 GENOME EDITING MARKET BY REGIONAL SEGMENTATION, 2018 VS 2025 (USD MILLION) 54

CHART 23 GENOME EDITING MARKET REVENUE IN NORTH AMERICA, 2018-2025 (USD MILLION) 56

CHART 24 GENOME EDITING MARKET REVENUE IN EUROPE 2018-2025 (USD MILLION) 57

CHART 25 GENOME EDITING MARKET REVENUE IN ASIA PACIFIC, 2018-2025 (USD MILLION) 58

CHART 26 GENOME EDITING REVENUE IN REST OF THE WORLD, 2018-2025 (USD MILLION) 59

CHART 27 THERMO FISHER SCIENTIFIC: OVERVIEW SNAPSHOT 66

CHART 28 THERMO FISHER SCIENTIFIC: BUSINESS UNITS 67

CHART 29 THERMO FISHER SCIENTIFIC: GEOGRAPHIC PRESENCE 68

CHART 30 THERMO FISHER SCIENTIFIC: SWOT ANALYSIS 69

CHART 31 GENSCRIPT CORPORATION: OVERVIEW SNAPSHOT 71

CHART 32 GENSCRIPT CORPORATION: BUSINESS UNITS 72

CHART 33 GENSCRIPT CORP.: GEOGRAPHIC PRESENCE 73

CHART 34 GENSCRIPT CORPORATION: SWOT ANALYSIS 74

CHART 35 SANGAMO THERAPEUTICS, INC.: OVERVIEW SNAPSHOT 76

CHART 36 SANGAMO THERAPEUTICS, INC.: SWOT ANALYSIS 78

CHART 37 LONZA GROUP: OVERVIEW SNAPSHOT 79

CHART 38 LONZA GROUP: BUSINESS UNITS 80

CHART 39 LONZA GROUP: GEOGRAPHIC PRESENCE 81

CHART 40 LONZA GROUP: SWOT ANALYSIS 82

CHART 41 HORIZON DISCOVERY GROUP PLC: OVERVIEW SNAPSHOT 85

CHART 42 HORIZON DISCOVERY GROUP PLC: BUSINESS UNITS 86

CHART 43 HORIZON DISCOVERY GROUP PLC: GEOGRAPHIC PRESENCE 87

CHART 44 HORIZON DISCOVERY GROUP PLC: SWOT ANALYSIS 88

 


List Of Table

Tables

 

TABLE 1 DEALS BETWEEN 2011-2016 23

TABLE 2 GENOME EDITING MARKET REVENUE, BY TECHNOLOGY TYPE, 2018-2025 (USD MILLION) 37

TABLE 3 GENOME EDITING MARKET REVENUE, BY APPLICATION TYPE, 2018-2025 (USD MILLION) 44

TABLE 4 GENOME EDITING MARKET REVENUE, BY PRODUCT TYPE, 2018-2025 (USD MILLION) 55

TABLE 5 COST COMPARISION OF GENOME EDITING TECHNOLOGY 60

TABLE 6 KEY DEVELOPMENTS IN THE MARKET 61

TABLE 7 THERMO FISHER SCIENTIFIC: PRODUCT OFFERINGS 65

TABLE 8 THERMO FISHER SCIENTIFIC: RECENT DEVELOPMENTS 66

TABLE 9 GENSCRIPT CORPORATION: PRODUCT OFFERINGS 71

TABLE 10 GENSCRIPT CORPORATION: RECENT DEVELOPMENTS 71

TABLE 11 SANGAMO THERAPEUTICS, INC.: PRODUCT OFFERINGS 76

TABLE 12 SANGAMO THERAPEUTICS, INC.: RECENT DEVELOPMENTS 76

TABLE 13 LONZA GROUP: OFFERINGS 79

TABLE 14 LONZA GROUP: RECENT DEVELOPMENTS 79

TABLE 15 HORIZON DISCOVERY GROUP PLC: OFFERINGS 84

TABLE 16 HORIZON DISCOVERY GROUP PLC: RECENT DEVELOPMENTS 84

TABLE 17 MERCK KGAA: SNAPSHOT 90

TABLE 18 MERCK KGAA: RECENT DEVELOPMENTS 90

TABLE 19 TRANSPOSAGEN BIOPHARMACEUTICALS: SNAPSHOT 91

TABLE 20 TRANSPOSAGEN BIOPHARMACEUTICALS: RECENT DEVELOPMENTS 91

TABLE 21 CRISPR THERAPEUTICS: OVERVIEW 92

TABLE 22 CRISPR THERAPEUTICS: RECENT DEVELOPMENTS 92

TABLE 23 EDITAS MEDICINE: OVERVIEW 93

TABLE 24 EDITAS MEDICINE: RECENT DEVELOPMENTS 93

TABLE 25 INTEGRATED DNA TECHNOLOGIES: SNAPSHOT 94

TABLE 26 INTEGRATED DNA TECHNOLOGIES: RECENT DEVELOPMENTS 94

TABLE 27 NEW ENGLAND BIOLABS: OVERVIEW 95

TABLE 28 NEW ENGLAND BIOLABS: RECENT DEVELOPMENTS 95

TABLE 29 ORIGENE TECHNOLOGIES, INC.: OVERVIEW 96

TABLE 30 ORIGENE TECHNOLOGIES, INC.: RECENT DEVELOPMENTS 96

 

?

"Single User $3,500- PDF via email with only 1 user license terms or online access with login details to customer
- Multi Users $4,000- PDF via email with up to 10 user license terms
- Enterprise License $5,000- PDF via email, can be utilized across the organization and can upload in their intranet.
We do have the online access for our reports where client can utilize our knowledge store and they will have their login details to access the report online instead of PDF file."

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Companies

ThermoFisher Scientific

GenScript Corp.

Sangamo Therapeutics

Lonza Group

Horizon Discovery Group plc

Merck KGaA

Transposagen Biopharmaceutical

CRISPR Therapeutics

Editas Medicine

Integrated DNA Technologies

New England Biolabs

Origene Technologies, Inc.